China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Tetrahydrobiopterin for the Prevention and Treatment of Hard-to-Heal Wounds: A Phase II Clinical Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133912
Registration Time: 2026/10/09
Type: Interventional study
Primary Sponsor: China National Nuclear Corporation 416 Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344979
Published by HT Digital Content Services with permission from Health Daily Digest....